Provided by Tiger Trade Technology Pte. Ltd.

Outlook Therapeutics, Inc.

0.5710
-0.0190-3.22%
Volume:2.01M
Turnover:1.16M
Market Cap:138.75M
PE:-0.76
High:0.5898
Open:0.5800
Low:0.5700
Close:0.5900
52wk High:2.54
52wk Low:0.1611
Shares:243.00M
Float Shares:198.00M
Volume Ratio:0.48
T/O Rate:1.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7479
EPS(LYR):-1.7940
ROE:-3.65%
ROA:-143.17%
PB:-13.35
PE(LYR):-0.32

Loading ...

Outlook Therapeutics Inc : Btig Raises to Buy from Neutral

THOMSON REUTERS
·
Jul 27

Outlook Therapeutics Gains Following FDA Approval of Macular-degeneration Drug

Dow Jones
·
Jul 25

NASDAQ Trade Halt Volatility Trading Pause at 03:00 Pm

Reuters
·
Jul 25

Outlook jumps 24% to $1.64 after FDA approves wet AMD treatment

TIPRANKS
·
Jul 25

Outlook Therapeutics Announces Lytenava FDA Approval for Treatment of Wet AMD

Reuters
·
Jul 25

US FDA Approves Outlook Therapeutics' Eye Disease Drug

Reuters
·
Jul 25

Outlook Therapeutics Inc: Anticipated 12 Years of Market Exclusivity Under Biologics Price Competition and Innovation Act

THOMSON REUTERS
·
Jul 25

Outlook Therapeutics - Lytenava Expected to be Available to U.S. Patients Before Year-end

THOMSON REUTERS
·
Jul 25

Outlook Therapeutics Announces Lytenava™ FDA Approval as the First and Only Fda-approved Ophthalmic Bevacizumab for the Treatment of Wet Amd

THOMSON REUTERS
·
Jul 25

Outlook Therapeutics Inc trading halted, news pending

TIPRANKS
·
Jul 25

NASDAQ Trade Halt Halt News Pending at 01:34 Pm

Reuters
·
Jul 25

Outlook Therapeutics Grants CEO, CFO Options at $1.43 Per Share

Reuters
·
Jul 24

Outlook Therapeutics Registers 17.3 Million Shares for Resale

MT Newswires Live
·
Jul 18

Outlook Therapeutics Shareholders Approve Increase in Authorized Common Shares to 600 Million

Reuters
·
Jul 17

Rocket Pharma Names Joseph Manhede Principal Accounting Officer, Effective July 8

Reuters
·
Jul 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: Outlook Therapeutics (OTLK), Praxis Precision Medicines (PRAX) and Merck & Company (MRK)

TIPRANKS
·
Jun 30

Outlook Therapeutics Regains Nasdaq Compliance

MT Newswires Live
·
Jun 29

Outlook Therapeutics Regains NASDAQ Compliance After Shares Hold Above $1 Bid Threshold

Reuters
·
Jun 27

Outlook Therapeutics Shares Surge After FDA Accepts Resubmitted Wet AMD Application

Dow Jones
·
Jun 16

BUZZ-Outlook Therapeutics rises after US FDA accepts to review eye disease treatment

Reuters
·
Jun 16